Quality of Life Patients After PCI with Drug-Eluting Stents

PCI anginafrequency subscale stents paclitaxel-eluting stents

Authors

January 28, 2025

This article focuses on evaluating the quality of life in patients with coronary artery disease after undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES). PCI is widely used as an alternative revascularization method to improve patients' quality of life. The study utilized the Seattle Angina Questionnaire (SAQ) to assess disease-specific health status, including angina frequency, physical limitations, and factors impacting overall quality of life. A total of 1,800 patients were observed over 12 months to monitor quality indicators. The results compared PCI with coronary artery bypass grafting (CABG). Findings revealed that PCI improved health-related quality of life during the initial month; however, at 6 and 12 months, CABG demonstrated superiority in reducing angina symptoms. This study highlights PCI's potential to enhance quality-of-life outcomes, even in cases of complex arterial disease, providing valuable insights into its effectiveness for long-term management of coronary artery conditions.